In South Australia, reporting of live births, stillbirths of at least 20 weeks or 400g birth weight, termination of pregnancies and congenital anomalies is mandated. We describe the investigation of an increase in notifications of neural tube defects (NTDs) in South Australia in 2009 and 2010 using data from several surveillance systems. Discussion: The increased notifications of NTDs can only be partially explained by the increase in numbers of women from the Middle East and African region, with no other contributory causes revealed. This analysis highlighted areas where prevention efforts should be strengthened and surveillance data improved.
T he neural tube usually closes by day 28 of prenatal life, and incomplete or incorrect closure results in malformations called neural tube defects (NTDs).
1, 2 There is a spectrum of severity of NTDs from anencephaly, which is incompatible with life beyond the neonatal period, to spina bifida occulta, which may be asymptomatic. Periconceptional folic acid supplementation has been shown to decrease the risk of NTDs.
23, 24 Folic acid supplementation one month prior and three months post conception is recommended to reduce the risk of an NTD-affected pregnancy.
4,25-27
In Australia, voluntary fortification of selected foods with folic acid was permitted from 1995, with fortification of non-organic, bread-making flour mandated from September 2009.
7
In South Australia, reporting of all births, induced termination of pregnancy (ITOP) procedures and congenital abnormalities to the Pregnancy Outcome Unit (POU) of the South Australian Department for Health and Ageing is mandated, 28 and form the Birth Defects
Register surveillance system. 
METHODS

Data sources
NTD trend data from 1966 to 2010 were accessed from the Birth Defects Register surveillance database. Information on NTD-affected pregnancies (excluding spina bifida occulta) was obtained from three sources:
• The Abortion Statistics Collection is based on the Doctors Certificate and Notice Schedule (ITOP procedure form). Notifiers must include "grounds for termination of pregnancy," with "suspected medical condition of fetus" specified.
• The Perinatal Statistics Collection, using the Supplementary Birth Record completed by hospital and home-birth midwives, records the outcome of all live births, stillbirths of at least 20 weeks duration or 400g birth weight and includes a question regarding congenital abnormalities apparent in the baby.
• The Birth Defects Register includes reports of an NTD within first year of life from the Congenital Abnormality Form, which is completed by the notifying medical officer, midwife or South Australian Birth Defects Register staff.
Although reporting of births, ITOP procedures and congenital abnormalities is legally required, information is not always complete. To ensure the accuracy and maximize the completeness of the database of NTD notifications for the period 2003-2010, the data items were verified against the following: Statistical analysis was undertaken using STATA 12. The level of significance was set at 5%. NTD prevalence trend was analysed with Poisson regression. Other analyses were undertaken using chi-squared tests with Fisher's exact test used where expected counts were less than five. Missing data were excluded from analyses. 
RESULTS
Prevalence of NTDs
The prevalence of NTDs was relatively stable between 1966 and 1990 and declined significantly thereafter Table 3) .
Women with NTD-affected pregnancies in 2009 and 2010 were less likely to be married or in a de facto 
DISCUSSION
This study aimed to investigate an observed increase in the number of NTD-affected pregnancies notified in 2009 and 2010 in South Australia using routinely collected surveillance data. No explanation was found that could fully account for the increase in NTD notifications; however, factors that were likely contributory were 1966  1967  1968  1969  1970  1971  1972  1973  1974  1975  1976  1977  1978  1979  1980  1981  1982  1983  1984  1985  1986  1987  1988  1989  1990  1991  1992  1993  1994  1995  1996  1997  1998  1999  2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 An elevated number of notifications can be due to a change in detection methods, a change in notification practices or a real increase in disease. Given the severe nature of most NTDs, the majority will be diagnosed either prenatally or within the first year of life; 1 therefore, it is unlikely that a change in detection methods could account for the increase in NTD notifications. Since 1998, the South Australian Births Defects Register has been screening childhood admission data for missing notifications; hence, it is unlikely that a change in notification practices could account for the increase in notifications. It is likely that the increase in NTD notifications reflected a real increase in the number of NTD-affected pregnancies and warranted further investigation.
Women with NTD-affected pregnancies in 2009 and 2010 in this study were less likely to be Caucasian and more likely to have been born in the Middle East and African region compared with women who had NTD-affected pregnancies in the period [2003] [2004] [2005] [2006] [2007] [2008] . Women born in the Middle East and African region were also significantly more likely to have NTD-affected pregnancies in the years 2009-2010 compared with women born in the Oceania region. Periconceptional folic acid is a key modifiable risk factor in NTD prevention, and several studies have noted reduced intake of folic acid supplementation in pregnant ethnic minority women compared with women of the ethnic majority.
33,34
Poor language proficiency is also likely a barrier to adequate folic acid supplementation. 34 Closer inspection of folate use among the Middle East and African-born women and Asian-born women with NTD-affected pregnancies in 2009 and 2010 did not reveal a consistent pattern of reduced folate consumption during pregnancy.
Of the women with NTD-affected pregnancies in 2009 and 2010, 69% reported taking folate (8% reported not taking folate during pregnancy; 23% had missing data). Recent data from the South Australian Monitoring and Surveillance System indicated that in 2010, 92.6% (95% CI: 88.4%-95.6%) of women currently pregnant or pregnant within the past three years reported taking folic acid supplementation in pregnancy.
35
Although these proportions are not directly comparable, there is evidence of the continued need for education of women regarding the importance of periconceptional folic acid.
Three women had two NTD-affected pregnancies within the 2003-2010 period. Women who have had one NTD-affected pregnancy have a 2%-3% chance of a subsequent NTD-affected pregnancy.
14 It would be expected that women who are multiparous would more likely be exposed to health promotion messages regarding folate during previous pregnancies and thus have a greater awareness of the need for periconceptional folic acid. 34 However, in our study, there was no significant difference between gravidity or parity and risk of an NTD-affected pregnancy. This is in keeping with a previously reported link between inadequate folate consumption and multiparity. 33 It is important that women of childbearing age at increased risk of NTD such as women with a previous NTD-affected pregnancy or family history of NTD are advised to take 5mg of folic acid supplementation daily orally as opposed to the 0.5 mg recommended for women not at increased risk.
25-27
This may represent opportunities missed by health services to inform pregnant women of the importance of periconceptional folic acid use in future pregnancies.
Inadequate vitamin B12 may also be associated with an increased risk of NTD.
10,12,13,36 Vitamin B12 deficiency is likely to be a public health issue in both developed and developing countries worldwide; however, there is a lack of population-based prevalence studies.
37
In a South Australian-based study of recently arrived refugees, no women of childbearing age (15- There have been no trials of vitamin B12 supplementation in pregnancy; hence, it is currently unknown whether vitamin B12 supplementation is of benefit in NTD prevention. 36 It may be that vitamin B12 supplementation in addition to folic acid supplementation is required to minimize the risk of NTD in this community. A recent study using South Australian data found no significant difference in risk of neurological congenial anomalies in pregnancies resulting from ART compared with all pregnancies.
40
Maternal hyperthermia in early pregnancy is associated with an increased risk of an NTD-affected pregnancy.
3,11,20,22
South Australia experienced an extreme heat wave in early 2009, 31 therefore, meteorological effects were analysed as a possible reason for increased numbers of women with NTD-affected pregnancies in 2009 and 2010. However, no significant difference was found. Improving methodologies to determine the association of meteorological effects on congenital anomalies is important as Australia is likely to experience more extreme weather conditions, including heat waves, in association with climate change.
31
This study, as it was based on surveillance and other routinely collected data, has several limitations. Data were obtained from three separate sources, each with a different focus and thus different variables. Missing data was also an issue, particularly for BMI, ART and folate status, making interpretation of these comparisons difficult. Folate consumption was only routinely collected for women with NTD-affected pregnancies with data frequently missing. Clinicians reported they were reluctant to question women with NTD-affected pregnancies, particularly those requesting ITOP, regarding their periconceptional folate intake given the sensitivity of the situation. As POU is not legally permitted to contact the women, this analysis had to rely on reported data.
Additionally, measurement bias was likely as notifications of pregnancies with no reported complications are subject to less scrutiny than pregnancies with reported congenital anomalies. Women with NTD-affected pregnancies, compared to women without complications, may be more likely to recall medical procedures (e.g. ART). Exclusion of women with previous NTDs from the analyses did not result in any significant difference from the results reported. As this study was based on an observed population, it involved small numbers, and therefore, multivariable analysis to control for potential confounders was not feasible.
This study has several strengths. It reported a wholeof-state collection of pregnancies with a NTD including both ITOP procedures and births. There was likely almost complete capture of NTD-affected pregnancies (excluding early miscarriages) due to mandatory reporting and routine screening for missed notifications. Additionally, trend data on NTD birth prevalence were available for more than 40 years.
In conclusion, a small but significant increase in the numbers of women born in the Middle East and African region partially contributed to the observed increase in notifications of NTD-affected pregnancies in South Australia in 2009 and 2010. However, this cannot fully explain the observed increase in NTD notifications, and it is likely that these two years of increased notifications represent a chance event rather than signalling the beginning of an epidemiological shift. This study highlighted the need for surveillance systems of congenital anomalies to be able to respond to such increases. It also drew attention to the need to improve universal health promotion messages regarding periconceptional folic acid supplementation in pregnancy and to further investigate other potentially contributory nutritional deficiencies such as vitamin B12, particularly among women born in the Middle East and Africa.
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